共 158 条
[1]
Van Belle TL(2011)Type 1 diabetes: etiology, immunology, and therapeutic strategies Physiol Rev 91 79-118
[2]
Coppieters KT(2010)Genetics, pathogenesis and clinical interventions in type 1 diabetes Nature 464 1293-1300
[3]
von Herrath MG(1994)Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice Proc Natl Acad Sci U S A 91 123-127
[4]
Bluestone JA(1997)CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice J Immunol 158 2947-2954
[5]
Herold K(2002)Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus N Engl J Med 346 1692-1698
[6]
Eisenbarth G(2005)A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes Diabetes 54 1763-1769
[7]
Chatenoud L(2005)Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes N Engl J Med 352 2598-2608
[8]
Thervet E(2010)Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients Blood 115 1145-1155
[9]
Primo J(2011)Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial Lancet 378 487-497
[10]
Bach JF(2003)Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators J Cell Biochem 88 223-226